VEGFA and colorectal carcinoma: In addition to these studies, others investigated safety and efficacy of the anti-vascular endothelial growth factor (VEGF) monoclonal antibody bevacizumab with chemotherapy and CRT in CRC [69,70,71] and RC [70,71,72] showing opposite results.